Currie Graeme Martin 4
4 · Pasithea Therapeutics Corp. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
Currie Graeme Martin
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2024-03-01+5,938→ 5,938 totalExercise: $8.34Exp: 2034-02-28→ Common Stock (5,938 underlying)
Footnotes (1)
- [F1]The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The Option fully vested upon issuance and became exercisable on March 1, 2024.